AMSTERDAM — SkinVision has raised $7.6 million in funding to continue the development of a skin cancer screening app. “This investment places SkinVision at the forefront of the integration of machine learning within health care,” said Erik de Heus, CEO of SkinVision, in a statement. The app uses clinically validated machine learning algorithms to check for visible signs of skin cancer, comparing lesions to the 3.5 million photos already checked by SkinVision dermatologists within its database. The technology indicates which skin spots should be tracked over time, giving a low, medium or high-risk indication within 30 seconds. All high-risk photos receive extra personal advice from doctors on next steps to take within 48 hours. “This funding will be instrumental in reaching our target of saving 250,000 lives by 2027. We have seen huge growth in the past year and this investment will help us to expand our insurance provider partnerships, ensuring that as many people as possible are provided access to the technology.” In May the company won the Dutch Digital Health Challenge for their work with Dutch health insurer CZ.
You are here: / / SkinVision raises $7.6M for skin cancer screening app